Skip to Main Content

Author Details

Hemal Mehta
The University of Sydney Save Sight Institute
2005
95
32
PMIDPaper TitleJournal TitlePublished Year
34340975Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.Br J Ophthalmol2023
38077060Investigating impacts of marine sponge derived mycothiazole and its acetylated derivative on mitochondrial function and aging.bioRxiv2023
37523432Novel Drug Delivery Methods and Approaches for the Treatment of Retinal Diseases.Asia Pac J Ophthalmol (Phila)2023
37898362From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema.Prog Retin Eye Res2023
35508721Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion.Eye (Lond)2023
37069239Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO).Eye (Lond)2023
36509655Reply.Ophthalmol Retina2023
36824442Diabetic Macular Oedema Guidelines: An Australian Perspective.J Ophthalmol2023
36658336Correction: Mitochondrial DNA variation in Alzheimer's disease reveals a unique microprotein called SHMOOSE.Mol Psychiatry2023
36371040Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! Registry.Ophthalmol Retina2023
35078771Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry.Br J Ophthalmol2023
33196150Initial observation or treatment for diabetic macular oedema with good visual acuity: two-year outcomes comparison in routine clinical practice: data from the Fight Retinal Blindness! Registry.Acta Ophthalmol2022
35760858Author Correction: Neuroimaging and cognitive correlates of retinal Optical Coherence Tomography (OCT) measures at late middle age in a twin sample.Sci Rep2022
35365706Bladder cancer cells shift rapidly and spontaneously to cisplatin-resistant oxidative phosphorylation that is trackable in real time.Sci Rep2022
35688899Neuroimaging and cognitive correlates of retinal Optical Coherence Tomography (OCT) measures at late middle age in a twin sample.Sci Rep2022
36241963Outcomes of Over 40,000 Eyes Treated for Diabetic Macula Edema in Routine Clinical Practice: A Systematic Review and Meta-analysis.Adv Ther2022
35952753Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration.Am J Ophthalmol2022
33712484Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.Br J Ophthalmol2022
35307607Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! Project.Ophthalmol Retina2022
35174799THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: Data from the Fight Retinal Blindness! Registry.Retina2022
3451916712-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry.Acta Ophthalmol2022
34624450Humanin-induced autophagy plays important roles in skeletal muscle function and lifespan extension.Biochim Biophys Acta Gen Subj2022
33420163Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples.Sci Rep2021
33881205Effect of intravitreal injection speed on acute rise in intraocular pressure. The SPEED IOP study.Clin Exp Ophthalmol2021
33743165Presumed Sertraline-Associated Maculopathy: A Case Series.Ophthalmol Ther2021
33840064Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion.Ophthalmol Ther2021
33554779MOTS-c reduces myostatin and muscle atrophy signaling.Am J Physiol Endocrinol Metab2021
34421178The ocular adverse effects of oral drugs.Aust Prescr2021
34201114Management of Cataract in Patients with Age-Related Macular Degeneration.J Clin Med2021
32383527Changes in real-world treatment patterns for diabetic macular oedema from 2009 to 2019 and 5-year outcomes: Data from the Fight Retinal Blindness! Registry.Clin Exp Ophthalmol2020
31932092Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry.Ophthalmology2020
31900438Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration.Eye (Lond)2020
31885185Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! Registry.Clin Exp Ophthalmol2020
33116384Trends in Real-World Neovascular AMD Treatment Outcomes in the UK.Clin Ophthalmol2020
32575074The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan.Aging (Albany NY)2020
32821522A Mitochondrial Genome-Wide Association Study of Cataract in a Latino Population.Transl Vis Sci Technol2020
32844137Mito-Omics and immune function: Applying novel mitochondrial omic techniques to the context of the aging immune system.Transl Med Aging2020
32699378Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.Eye (Lond)2020
32313172A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion.Eye (Lond)2020
32504038Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.Eye (Lond)2020
32387288Peptides derived from small mitochondrial open reading frames: Genomic, biological, and therapeutic implications.Exp Cell Res2020
30657335Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid-induced bone growth impairment.FASEB J2019
30092239Relationship between Retinal Thickness Profiles and Visual Outcomes in Young Adults Born Extremely Preterm: The EPICure@19 Study.Ophthalmology2019
30084193Dexamethasone implant for the treatment of persistent diabetic macular oedema despite long-term treatment with bevacizumab.Clin Exp Ophthalmol2019
31293078The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity.Physiol Rep2019
30987182Comparing the Utility of Mitochondrial and Nuclear DNA to Adjust for Genetic Ancestry in Association Studies.Cells2019
31014709Development of New Proliferative Diabetic Retinopathy in the BEVORDEX Trial.Ophthalmol Retina2019
30980914Effects of air pollution on mitochondrial function, mitochondrial DNA methylation, and mitochondrial peptide expression.Mitochondrion2019
31172328Metabolomic profile of diet-induced obesity mice in response to humanin and small humanin-like peptide 2 treatment.Metabolomics2019
28779007Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema.Br J Ophthalmol2018
  • 1 - 50 of 95

Recommended Authors

National Eye Institute, National Institutes of Health.
Career Start Year 2013
Number of shared co-authors 2
Research Centre, Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2012
Number of shared co-authors 8
NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 2011
Number of shared co-authors 7
West China Hospital, Sichuan University
Career Start Year 2008
Number of shared co-authors 1
Shiley Eye Institute, University of San Diego
Career Start Year 2007
Number of shared co-authors 1
Singapore Eye Research Institute
Career Start Year 2007
Number of shared co-authors 7
West China Hospital, Sichuan University
Career Start Year 2006
Number of shared co-authors 1
Universidade Federal de Sao Paulo
Career Start Year 2006
Number of shared co-authors 0
Jaeb Center for Health Research
Career Start Year 2006
Number of shared co-authors 3
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic
Career Start Year 2005
Number of shared co-authors 3
National Eye Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 9
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Career Start Year 2000
Number of shared co-authors 7
University Hospitals Birmingham NHS Foundation Trust
Career Start Year 2000
Number of shared co-authors 17
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital
Career Start Year 1999
Number of shared co-authors 23
Queen's University Belfast
Career Start Year 1999
Number of shared co-authors 18
University of California davis
Career Start Year 1998
Number of shared co-authors 0
University of California San Diego
Career Start Year 1995
Number of shared co-authors 2
University of Southampton
Career Start Year 1994
Number of shared co-authors 22
Washington University School of Medicine
Career Start Year 1994
Number of shared co-authors 5
Newcastle Hospitals NHS Foundation Trust
Career Start Year 1993
Number of shared co-authors 19
Wills Eye Hospital/Mid Atlantic Retina
Career Start Year 1992
Number of shared co-authors 5
Byers Eye Institute, Stanford University
Career Start Year 1990
Number of shared co-authors 7
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 5
Frimley Health NHS Foundation Trust
Career Start Year 1988
Number of shared co-authors 16
Queen's University Belfast
Career Start Year 1985
Number of shared co-authors 21
Jaeb Center for Health Research
Career Start Year 1984
Number of shared co-authors 3
National Eye Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 18
University of Wisconsin, Wisconsin EyeKor Inc.
Career Start Year 1981
Number of shared co-authors 6
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1979
Number of shared co-authors 2
National Eye Institute, National Institutes of Health
Career Start Year 1962
Number of shared co-authors 4

Collaborators

The University of Sydney Save Sight Institute
Co-authored papers 34
The University of Sydney Save Sight Institute
Co-authored papers 24
University Hospital Zurich and University of Zurich
Co-authored papers 16
University of Western Australia, Lions Eye Institute
Co-authored papers 9
Hull and East Yorkshire Hospital, Hull and East Yorkshire NHS Trust
Co-authored papers 6
Institute of Ophthalmology, University College London
Co-authored papers 6
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 6
Hospital Clinic of Barcelona, University of Barcelona
Co-authored papers 6
Co-authored papers 4
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 4
University of Manchester
Co-authored papers 4
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 4
NIHR Moorfields Biomedical Research Centre
Co-authored papers 3
Bradford Teaching Hospitals NHS Foundation Trust
Co-authored papers 3
Ophthalmology Clinic, Haseki Training and Research Hospital
Co-authored papers 2
Hull York Medical School, University of York
Co-authored papers 2
Co-authored papers 2
UCL Institute of Ophthalmology
Co-authored papers 2
Harvard University, Moorfields Eye Hospital NHS Foundation Trust, St. John's Mercy Hospital, University of British Columbia, University of Washington, Washington University in Saint Louis
Co-authored papers 2
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 2
Co-authored papers 2
University of Manchester
Co-authored papers 2
Co-authored papers 2
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust
Co-authored papers 1
Keck School of Medicine, University of Southern California
Co-authored papers 1
Moorfields Eye Hospital NHS Foundation Trust
Co-authored papers 1
Salk Institute for Biological Studies
Co-authored papers 1
Vanderbilt University School of Medicine
Co-authored papers 1
Royal Victoria Infirmary
Co-authored papers 1
Doheny Eye Institute, University of California Los Angeles
Co-authored papers 1